Chikungunya Virus

10 registered clinical trials studyying Chikungunya Virus — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Phase I Study of PepGNP-ChikV in Healthy Volunteers NCT07394426	Gylden Pharma Ltd	EARLY_Phase 1
Not Yet Recruiting	An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease i NCT07467707	Bavarian Nordic	Phase 3
Recruiting	A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. NCT07003984	Bavarian Nordic	Phase 3
Completed	Trial of an Inactivated Chikungunya Virus Vaccine NCT06669208	Najit Technologies, Inc.	Phase 1
Completed	Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years NCT05349617	Bavarian Nordic	Phase 3
Completed	A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine NCT05065983	Bavarian Nordic	Phase 2
Completed	A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) NCT05072080	Bavarian Nordic	Phase 3
Completed	Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants NCT03325075	ModernaTX, Inc.	Phase 1
Completed	A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet C NCT02305732	Cerus Corporation	—
Terminated	CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease NCT00391313	Assistance Publique Hopitaux De Marseille	Phase 3